Literature DB >> 6430705

A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.

D P Thornhill, C Steffen, K J Netter.   

Abstract

The pharmacokinetics of the blood level and the patterns of 14CO2 exhalation were determined simultaneously following i.v. administration of 14C-methacetin to the conscious rat. The pattern of exhalation of 14CO2 did not parallel the biexponential decline of radioactivity in the blood and a delay of 30-40 min preceded the maximal rate of 14CO2 exhalation. The total radioactivity exhaled remained constant at 56 +/- 4.5% (SD) of the applied dose throughout a tenfold dose range of methacetin (0.6, 4.0 and 6.0 mg/kg i.p.), administered to groups of three rats each and measured over a period of 4 hours. The pattern of radiolabel exhalation was biexponential with the low dose, linear with the medium dose and convex with the high dose. Although the total fraction of the label expired after 4 hours remained constant, the rates of exhalation at the higher dosages exhibited saturation type kinetics. At the higher dosage, since the pattern of 14CO2 exhalation did not accurately reflect the decline of methacetin seen in blood, one of the steps occurring between the demethylation process and the production of expired CO2 appears to be rate limiting. Significant increases in the amount of 14CO2 exhaled within 1 hour were obtained by pretreatment with phenobarbital, rifampicin and 3-methylcholanthrene. Again the proportion of radiolabel expired in 4 hours remained constant. Acute hepatic injury produced by pretreatment with graded doses of carbon tetrachloride resulted in graded reductions in the amount of 14CO2 exhaled in the first hour, although the total amount exhaled during the 4 hour collection period did not change.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430705     DOI: 10.1007/BF03189620

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  21 in total

1.  Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.

Authors:  G W Hepner; E S Vesell
Journal:  N Engl J Med       Date:  1974-12-26       Impact factor: 91.245

2.  The disposition of formaldehyde and formate arising from drug N-demethylations dependent on cytochrome P-450 in hepatocytes and in perfused rat liver.

Authors:  C Waydhas; K Weigl; H Sies
Journal:  Eur J Biochem       Date:  1978-08-15

3.  Comparison of [14C] phenacetin and amino[14C]pyrine breath tests after acute and chronic liver injury in the rat.

Authors:  P V Desmond; R A Branch; I Calder; S Schenker
Journal:  Proc Soc Exp Biol Med       Date:  1980-06

4.  Validation of 13CO2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man.

Authors:  J F Schneider; D A Schoeller; B Nemchausky; J L Boyer; P Klein
Journal:  Clin Chim Acta       Date:  1978-03-01       Impact factor: 3.786

5.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.

Authors:  B H Lauterburg; J Bircher
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

6.  Aminopyrine demethylation kinetics. Use of metabolite exhalation rates as an index of enhanced mixed-function oxidase activity in vivo.

Authors:  J B Houston; G F Lockwood; G Taylor
Journal:  Drug Metab Dispos       Date:  1981 Sep-Oct       Impact factor: 3.922

7.  Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

Authors:  I Gikalov; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

8.  Studies of the metabolism of N-methyl containing anti-tumour agents: 14CO2 breath analysis after administration of 14C-labelled N-methyl drugs, formaldehyde and formate in mice.

Authors:  A Gescher; C Raymont
Journal:  Biochem Pharmacol       Date:  1981-06-01       Impact factor: 5.858

9.  Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.

Authors:  G W Hepner; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

10.  Hybrid information provided by the 14C-aminopyrine breath test. Studies with 14C-monomethylaminoantipyrine in the guinea pig.

Authors:  I Roots; S Nigam; S Gramatzki; G Heinemeyer; A G Hildebrandt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

View more
  1 in total

1.  Assessment of hepatic detoxification activity: proposal of an improved variant of the (13)c-methacetin breath test.

Authors:  Hermann-Georg Holzhütter; Johan Friso Lock; Pouria Taheri; Sascha Bulik; Andrean Goede; Martin Stockmann
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.